{SA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cancer Research, Cell Biology, Cell Signaling and Neuroscience, EGFR Tyrosine Kinase Inhibitors, Epidermal Growth Factor Receptor & ErbII (EGFR/ErbB-2), G, GlaxoSmithKli
{SNA} Approved Therapeutics/Drug C
相关文献及参考
Rusnack, D. W., et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. CRC Handbook of Microbiology 61 , 7196, (2001)
安全信息
WGK Germany
3
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter